Black Diamond Therapeutics shares owned by Sherbrooke Park Advisers
Quarter-by-quarter ownership of Black Diamond Therapeutics (BDTX) shares owned by Sherbrooke Park Advisers
from 13F filings
Historical chart of Sherbrooke Park Advisers investment in Black Diamond Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Black Diamond Therapeutics held by Sherbrooke Park Advisers consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Black Diamond Therapeutics by Sherbrooke Park Advisers
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-12-31 | $29k | 12k | 2.43 |
| 2024-03-31 | $55k | 11k | 5.07 |